CDC: What Do Health Care Providers Need To Do? ............ Healthcare providers should maintain a high index of suspicion for vitamin K-dependent antagonist coagulopathy in patients with a history of synthetic cannabinoids (e.g., K2, Spice, and AK47) use:.................Presenting with clinical signs of coagulopathy, bleeding unrelated to an injury, or bleeding without another explanation; some patients may not divulge use of synthetic cannabinoids...................Presenting with complaints unrelated to bleeding (e.g., appendicitis).
University of Colorado: Registration: To register visit http://medschool.ucdenver.edu/cme or contact Pam Welker at (303)724-3551 or at firstname.lastname@example.org
USRDS: US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States
NEJM: Conclusions: Among critically ill adults, the use of balanced crystalloids for intravenous fluid administration resulted in a lower rate of the composite outcome of death from any cause, new renal-replacement therapy, or persistent renal dysfunction than the use of saline.
NEJM: Balanced crystalloids resulted in a lower incidence of major adverse kidney events within 30 days than saline (4.7% vs. 5.6%; adjusted odds ratio, 0.82; 95% CI, 0.70 to 0.95; P=0.01).